Dr. Reddy’s Laboratories announced the appointment of Marc Kikuchi as Chief Executive Officer, North America Generics. As part of the Dr. Reddy’s senior leadership team, he will be responsible for the company’s North America Generics business and will be based in Princeton office, U.S.
“Dr. Reddy’s is a great company with a wide portfolio and remarkable heritage,” said Kikuchi. “I am excited to join Dr. Reddy’s and look forward to leveraging my past experiences to steer the company’s new growth areas.”
Kikuchi has over 20 years of experience in the Pharmaceutical Industry with extensive knowledge and understanding of Generics. Marc joins Dr. Reddy’s from Zydus Pharmaceuticals where he served as CEO, Americas since 2016. Prior to joining Zydus, he held professional leadership roles of increasing responsibility with AmerisourceBergen Corporation, Medrad, PRTM, Johnson & Johnson and Incyte Pharmaceuticals. Kikuchi holds a Bachelor’s Degree in Molecular and Cell Biology with a Biochemistry emphasis from the University of California at Berkeley and Master of Business Administration from Carnegie Mellon University in Strategy, Marketing, and Operations Management.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!